Results 41 to 50 of about 48,203 (352)
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling [PDF]
, 2003 <b>Objective:</b> Chronic beta-adrenoceptor antagonist (β-blocker) treatment reduces the incidence of reversion to AF in patients, possibly via an adaptive myocardial response.
Kane, K.A. +4 more
core +1 more source
An Unusual Congenital Heart Disease: Giant Left Atrial Appendage
Methodist DeBakey Cardiovascular Journal, 2022 A 52-year-old female was admitted to our hospital in April 2021 with dyspnea. She was discharged from the hospital 3 weeks ago due to the diagnosis of pneumonia caused by coronavirus disease 2019 (COVID-19).
Julio C. Sauza-Sosa +2 more
doaj +1 more source
Limited Ability to Activate Protein C Confers Left Atrial Endocardium A Thrombogenic Phenotype: A Role in Cardioembolic Stroke? [PDF]
, 2011 Background and Purpose—Atrial fibrillation is the most important risk factor for cardioembolic stroke. Thrombi form in the left atrial appendage rather than in the right. The causes of this different thrombogenicity are not well-understood.
Cervero, J. (Jorge) +4 more
core +1 more source
Anatomy of the right atrial appendage and its importance in clinical practice
Folia MorphologicaThe right atrial appendage is an important anatomical marker of the right heart. With the developments in cardiology, more attention has been paid to the right atrial appendage.
Jiani Zhang, Mingyuan Yuan
doaj +1 more source
La orejuela izquierda como fuente de accidentes cerebrovasculares: cerrar (y cómo), o no cerrar (y por qué) [PDF]
, 2012 The left atrial appendage is considered the main source of emboli in strokes in patients with atrial fibrillation. Oral anticoagulant therapy significantly reduces the risk of cerebral embolic events compared to aspirin, but it is ...
Hernandez-Estefania, R. (Rafael) +2 more
core
Short and Intermediate Term Outcomes of the Convergent Procedure: Initial Experience in a Tertiary Referral Center [PDF]
, 2020 PURPOSE: The Convergent procedure is a hybrid, multidisciplinary treatment for symptomatic atrial fibrillation (AF) consisting of minimally invasive surgical epicardial ablation and percutaneous/catheter endocardial ablation.
Hirsh, Jeffrey +4 more
core +1 more source
Left atrial appendage occlusion.
International journal of preventive medicine, 2013 Left atrial appendage (LAA) occlusion is a treatment strategy to prevent blood clot formation in atrial appendage. Although, LAA occlusion usually was done by catheter-based techniques, especially percutaneous trans-luminal mitral commissurotomy (PTMC), it can be done during closed and open mitral valve commissurotomy (CMVC, OMVC) and mitral valve ...
Ahmad Mirdamadi +3 more
openaire +3 more sources
Left Atrial Appendage Exclusion for Atrial Fibrillation [PDF]
Heart Failure Clinics, 2014 Percutaneous left atrial appendage (LAA) closure is being increasingly used as a treatment strategy to prevent stroke in patients with atrial fibrillation (AF) who have contraindications to anticoagulants. Several approaches and devices have been developed in the last few years, each with their own unique set of advantages and disadvantages.
Faisal F, Syed +3 more
openaire +3 more sources
Advanced Healthcare Materials, EarlyView.Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao +2 more
wiley +1 more source
Рациональная фармакотерапия в кардиологии, 2015 Some aspects of prevention of thromboembolic events in patients with atrial fibrillation, in particular, the use of implantable left atrial appendage occluding devices are discussed.
K. V. Davtyan +3 more
doaj +3 more sources